Published in J Immunol on June 01, 1970
The biological activities of soluble lymphocyte products. Clin Exp Immunol (1972) 2.58
Trypanosoma cruzi: the immunological induction of macrophage plasminogen activator requires thymus-derived lymphocytes. J Exp Med (1977) 1.74
Production of macrophage migration inhibition factor by continuous cell lines. J Exp Med (1972) 1.62
Mouse cytomegalovirus. Necrosis of infected and morphologically normal submaxillary gland acinar cells during termination of chronic infection. Am J Pathol (1972) 1.48
In vitro synthesis of IgE by human lymphocytes. III. IgE-potentiating activity of culture supernatants from Epstein-Barr virus (EBV) transformed B cells. Immunology (1984) 1.44
Role of T lymphocytes in cellular immune responses during herpes simplex virus infection in humans. Proc Natl Acad Sci U S A (1978) 1.35
Immunocompetent cells in resistance to bacterial infections. Bacteriol Rev (1976) 1.31
Requirement for T cells in the production of migration inhibitory factor. J Exp Med (1975) 1.26
Lymphotoxin formation by lymphocytes and muscle in polymyositis. J Clin Invest (1972) 1.26
Alloantigens of human lymphoid cell lines; 'human Ia-like antigens'. Alloantigenic activity and cell line, organ and tissue distribution as determined by radioimmunoassay. Immunology (1977) 1.23
Human T-cell heterogeneity as delineated with a specific human thymus lymphocyte antiserum. In vitro effects on mitogen response mixed leukocyte culture, cell-mediated lymphocytotoxicity, and lymphokine production. J Clin Invest (1975) 1.16
Products of lymphoid cells in continuous culture. Am J Pathol (1970) 1.10
Role of lymphotoxin in expression of interleukin 6 in human fibroblasts. Stimulation and regulation. J Clin Invest (1990) 1.00
Lymphocyte-mediated cytotoxicity in vitro. Effect of enhancing antisera. J Exp Med (1971) 0.91
Cytotoxic effects of activated lymphocytes and their supernatants. Clin Exp Immunol (1973) 0.80
Inhibition of the mitogenic response of normal peripheral lymphocytes by extracts or supernatant fluids of a Herpesvirus saimiri lymphoid tumor cell line. Infect Immun (1975) 0.79
Pluronic polyols in human lymphocyte cell line cultures. J Clin Microbiol (1975) 0.75
The biochemistry of lymphocyte-derived mediators of immunological inflammation. Agents Actions (1978) 0.75
A suppressor lymphokine produced by human T leukemia cell lines. Partial characterization and spectrum of activity against normal and malignant hemopoietic cells. J Exp Med (1986) 0.75
Partial characterization of an immunoenhancing factor from allogeneic human lymphocyte cell lines. Immunology (1976) 0.75
The embryonic cell lineage of the nematode Caenorhabditis elegans. Dev Biol (1983) 21.29
A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature (1998) 12.07
In vitro bactericidal capacity of human polymorphonuclear leukocytes: diminished activity in chronic granulomatous disease of childhood. J Clin Invest (1967) 10.26
Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes. J Natl Cancer Inst (1972) 10.15
The neural circuit for touch sensitivity in Caenorhabditis elegans. J Neurosci (1985) 7.13
Natural adjuvants: endogenous activators of dendritic cells. Nat Med (1999) 7.10
Electron microscopical reconstruction of the anterior sensory anatomy of the nematode Caenorhabditis elegans.?2UU. J Comp Neurol (1975) 6.58
Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature (2000) 5.86
Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell (1990) 5.73
Neonatal tolerance revisited: turning on newborn T cells with dendritic cells. Science (1996) 5.31
Complement (C5-a)-induced granulocyte aggregation in vitro. A possible mechanism of complement-mediated leukostasis and leukopenia. J Clin Invest (1977) 5.16
Sequence and analysis of chromosome 4 of the plant Arabidopsis thaliana. Nature (1999) 5.03
Fine structural alterations induced in platelets by adenosine diphosphate. Blood (1968) 4.95
Cortical flow in animal cells. Science (1988) 4.66
Lymphocyte in vitro cytotoxicity: mechanisms of immune and non-immune small lymphocyte mediated target L cell destruction. J Immunol (1968) 4.66
An evaluation of confocal versus conventional imaging of biological structures by fluorescence light microscopy. J Cell Biol (1987) 4.59
Culture of normal human leukocytes. JAMA (1967) 4.50
Multiphoton excitation provides optical sections from deeper within scattering specimens than confocal imaging. Biophys J (1998) 4.44
On the control of germ cell development in Caenorhabditis elegans. Dev Biol (1981) 4.28
Determination of cell division axes in the early embryogenesis of Caenorhabditis elegans. J Cell Biol (1987) 4.20
B cells turn off virgin but not memory T cells. Science (1992) 4.12
The structure of the ventral nerve cord of Caenorhabditis elegans. Philos Trans R Soc Lond B Biol Sci (1976) 3.94
Danger signals: SOS to the immune system. Curr Opin Immunol (2001) 3.91
Regulation and cell autonomy during postembryonic development of Caenorhabditis elegans. Dev Biol (1980) 3.88
Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1. Nat Genet (2000) 3.50
Long-term two-photon fluorescence imaging of mammalian embryos without compromising viability. Nat Biotechnol (1999) 3.44
Activation events during thymic selection. J Exp Med (1992) 3.43
Molecular analysis of the membrane attack mechanism of complement. J Exp Med (1972) 3.35
T cell memory is short-lived in the absence of antigen. J Exp Med (1991) 3.16
Hypothesis: why do so many lymphocytes respond to major histocompatibility antigens? Cell Immunol (1977) 3.13
Gamma chain required for naïve CD4+ T cell survival but not for antigen proliferation. Nat Immunol (2000) 3.10
Platelet interaction with bacteria. I. Reaction phases and effects of inhibitors. Am J Pathol (1971) 3.04
Fluorescein as an Agent in the Differentiation of Normal and Malignant Tissues. Science (1947) 2.92
The C. elegans zyg-1 gene encodes a regulator of centrosome duplication with distinct maternal and paternal roles in the embryo. Cell (2001) 2.92
Cognitive decline in women in relation to non-protein-bound oestradiol concentrations. Lancet (2000) 2.82
Use of Radioactive Diiodofluorescein in the Diagnosis and Localization of Brain Tumors. Science (1948) 2.74
Completion of cytokinesis in C. elegans requires a brefeldin A-sensitive membrane accumulation at the cleavage furrow apex. Curr Biol (2001) 2.64
On the mechanisms of cytokinesis in animal cells. J Theor Biol (1983) 2.63
Cortical and cytoplasmic flow polarity in early embryonic cells of Caenorhabditis elegans. J Cell Biol (1993) 2.54
The dynactin complex is required for cleavage plane specification in early Caenorhabditis elegans embryos. Curr Biol (1998) 2.53
SSC1, an essential member of the yeast HSP70 multigene family, encodes a mitochondrial protein. Mol Cell Biol (1989) 2.52
Successful T cell priming in B cell-deficient mice. J Exp Med (1995) 2.52
Production of free light chains of immunoglobulin by a hematopoietic cell line derived from a patient with multiple myeloma. Proc Soc Exp Biol Med (1967) 2.47
The T-box transcription factor gene TBX22 is mutated in X-linked cleft palate and ankyloglossia. Nat Genet (2001) 2.46
The membrane attack mechanism of complement. Verification of a stable C5-9 complex in free solution. J Exp Med (1973) 2.44
Abnormal adherence of sickle erythrocytes to cultured vascular endothelium: possible mechanism for microvascular occlusion in sickle cell disease. J Clin Invest (1980) 2.34
Can B cells turn on virgin T cells? Nature (1988) 2.34
Interaction of membrane systems in blood platelets. Am J Pathol (1972) 2.32
The membrane attack mechanism of complement. Isolation and subunit composition of the C5b-9 complex. J Exp Med (1975) 2.32
Cell lines from human colon carcinoma with unusual cell products, double minutes, and homogeneously staining regions. Cancer Res (1979) 2.31
Specific degranulation of human polymorphonuclear leukocytes. Nature (1974) 2.30
Surgical adjuvant chemotherapy in cancer of the breast: results of a decade of cooperative investigation. Ann Surg (1968) 2.29
Selective labilization of specific granules in polymorphonuclear leukocytes by phorbol myristate acetate. Am J Pathol (1974) 2.27
Lymphocyte cytotoxicity in vitro: activation and release of a cytotoxic factor. Nature (1968) 2.24
An ultrastructural basis for the shape changes induced in platelets by chilling. Blood (1967) 2.20
Mice lacking the basolateral Na-K-2Cl cotransporter have impaired epithelial chloride secretion and are profoundly deaf. J Biol Chem (1999) 2.15
SSC1, a member of the 70-kDa heat shock protein multigene family of Saccharomyces cerevisiae, is essential for growth. Proc Natl Acad Sci U S A (1987) 2.10
A fail-safe mechanism for maintaining self-tolerance. J Exp Med (1992) 2.10
The ultrastructural localization and release of platelet lipids. Blood (1966) 2.10
Selection by two powerful antigens may account for the presence of the major population of human peripheral gamma/delta T cells. J Exp Med (1991) 2.09
Limited evolutionary conservation of imprinting in the human placenta. Proc Natl Acad Sci U S A (2006) 2.08
Kinetics and mechanisms of recombinant human interleukin 1 and tumor necrosis factor-alpha-induced changes in circulating numbers of neutrophils and lymphocytes. J Immunol (1987) 2.08
ADH1B is associated with alcohol dependence and alcohol consumption in populations of European and African ancestry. Mol Psychiatry (2011) 2.05
Dynamics and ultrastructure of developmental cell fusions in the Caenorhabditis elegans hypodermis. Curr Biol (1998) 2.04
Purification of the sixth and seventh component of human complement without loss of hemolytic activity. J Immunol (1976) 2.02
Biochemical studies of two patients with the gray platelet syndrome. Selective deficiency of platelet alpha granules. J Clin Invest (1980) 2.01
Corticosteroids inhibit complement-induced granulocyte aggregation. A possible mechanism for their efficacy in shock states. J Clin Invest (1979) 2.01
Activation of flavin-containing oxidases underlies light-induced production of H2O2 in mammalian cells. Proc Natl Acad Sci U S A (1999) 2.00
Bone-marrow oedema syndrome and transient osteoporosis of the hip. An MRI-controlled study of treatment by core decompression. J Bone Joint Surg Br (1993) 1.99
Mitogenic properties of a calcium ionophore, A23187. Proc Natl Acad Sci U S A (1974) 1.98
Fivefold enlargement of implants in a splenic autotransplant recipient. Surgery (1993) 1.96
Lymphocyte in vitro cytotoxicity: characterization of human lymphotoxin. Proc Natl Acad Sci U S A (1968) 1.95
Culture of human leukemia cells. Cancer (1966) 1.94
Lymphocyte in vitro cytotoxicity: specific release of lymphotoxin-like materials from tuberculin-sensitive lymphoid cells. Nature (1969) 1.94
The Chediak-Higashi syndrome: a possible lysosomal disease. Blood (1966) 1.94
Immunity or tolerance: opposite outcomes of microchimerism from skin grafts. Nat Med (2001) 1.93
Effects of phorbol myristate acetate on the metabolism and ultrastructure of neutrophils in chronic granulomatous disease. J Clin Invest (1974) 1.92
The influence of phorbol myristate acetate on oxygen consumption by polymorphonuclear leukocytes. J Lab Clin Med (1974) 1.92
T-cell control of IL-12p75 production. Scand J Immunol (2006) 1.92
Efficient, inefficient, and abortive infection of different mammalian cells by small RNA viruses. Virology (1967) 1.88
Chromatographic alterations in transfer RNA's accompanying speciation, differentiation and tumor formation. J Mol Biol (1968) 1.88
Tumor and lymphoid cell lines from a patient with carcinoma of the colon for a cytotoxicity model. Cancer Res (1978) 1.86
Evidence for channeled diffusion of pre-mRNAs during nuclear RNA transport in metazoans. J Cell Biol (1993) 1.85
Replication occurs at discrete foci spaced throughout nuclei replicating in vitro. J Cell Sci (1989) 1.84
Complement-dependent proinflammatory properties of the Alzheimer's disease beta-peptide. J Exp Med (1998) 1.84
The C5b-6 complex: formation, isolation, and inhibition of its activity by lipoprotein and the S-protein of human serum. J Immunol (1978) 1.81
Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes. Am J Hum Genet (2001) 1.80
In a fully H-2 incompatible chimera, T cells of donor origin can respond to minor histocompatibility antigens in association with either donor or host H-2 type. J Exp Med (1978) 1.79
The genetic aetiology of Silver-Russell syndrome. J Med Genet (2007) 1.78
Lymphokine toxicity for yeast cells. J Immunol (1973) 1.78
Homograft target cells: contact destruction in vitro by immune macrophages. Science (1966) 1.77
Effect of a short course of prednisone in the prevention of early relapse after the emergency room treatment of acute asthma. N Engl J Med (1991) 1.74
The in vitro induction and release of a cell toxin by immune C57B1-6 mouse peritoneal macrophages. Cell Immunol (1972) 1.73
Influence of cytochalasin B on the shape change induced in platelets by cold. Blood (1973) 1.72
Platelet interaction with bacteria. II. Fate of the bacteria. Am J Pathol (1971) 1.71
Gamma/delta T cells express a unique surface molecule appearing late during thymic development. Eur J Immunol (1989) 1.70
The life span of the cultured normal cell: concepts derived from studies of human lymphoblasts. J Theor Biol (1968) 1.68